Comparison of Neoadjuvant Chemotherapy Efficiency in Advanced Ovarian Cancer Patients Treated With Paclitaxel Plus Carboplatin and Intraperitoneal Bevacizumab vs. Paclitaxel With Carboplatin

OBJECTIVE: This study evaluated the role of neoadjuvant chemotherapy (NACT) with bevacizumab intraperitoneal perfusion in advanced ovarian cancer (AOC). METHODS: In this study, 80 patients with advanced epithelial ovarian cancer (stage IIIc or IV) who received NACT at the Central Hospital of Zhuzhou...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Yin, Tang, Xue-Ting, Li, Xing, Wu, An-Shan, Zhou, Hou-Shen, Zhou, Cheng-fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959569/
https://www.ncbi.nlm.nih.gov/pubmed/35355595
http://dx.doi.org/10.3389/fmed.2022.807377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959569/
https://www.ncbi.nlm.nih.gov/pubmed/35355595
http://dx.doi.org/10.3389/fmed.2022.807377

Ejemplares similares